EHA-LSHBT Hematology Update on Anticoagulation & AML

LSHBT logo2

EHA and the Lebanese Society of Hematology and Blood Transfusion (LSHBT) invite you to the third webinar of the Hematology Updates course.

This 2,5 hour workshop focussed on anticoagulation & AML and through keynote presentations and patient cases treatment strategies were discussed. Participants could join and submit all their questions to the faculty of the workshop in the Q&A panel discussions.

Live session date: May 6, 2021
Live session time: 17:00 – 19:30 EEST*
Chairs: G Gaidano (IT),  A Taher (LB)
*The program is scheduled in EET (Eastern European Time). Please check carefully what time this is for you.

Target audience

The main target audience is hematologists in North Africa & Middle East, but the course is open to attend for all.


  • Opening & Welcome
  • Session 1: Anticoagulation
    • Case Presentation: Patient with High Thrombophilic Risk: Is there one correct answer? - F Kreidieh (LB)
    • Keynote Presentation: Recent advances in anticoagulation: From prophylaxis to treatment
      S Temraz (LB)
    • Q&A Panel Discussion
  • Session 2: AML
    • Case Presentation: Title and speaker to be announced
    • Keynote Presentation: Target therapy in acute myeloid leukemia
      G Ossenkoppele (NL)
    • Q&A Panel Discussion
  • Closing Remarks

Cancellation of registration

Should you wish to cancel your registration then please contact

EBAH accredited stamp DEF2


Continuing Medical Education (CME) is widely accepted to encourage individual practitioners to maintain and develop professional knowledge and skills keeping up-to-date with latest developments within the field.

The EHA-LSHBT Virtual Hematology Updates are accredited by the EBAH system. Participants who join the live webinars of the EHA-LSHBT Virtual Hematology Series are eligible to receive 2.5 CME credit points per course. Participants who watch the on-demand recording of the webinar are eligible to receive one (1) CME point.